相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells
David L. Schonberg et al.
CANCER CELL (2015)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
Synthesis and Biological Properties of Quilamines II, New Iron Chelators with Antiproliferative Activities
Vincent Corce et al.
BIOCONJUGATE CHEMISTRY (2014)
Effects of iron depletion on CALM-AF10 leukemias
Jessica L. Heath et al.
EXPERIMENTAL HEMATOLOGY (2014)
Iron chelators induce autophagic cell death in multiple myeloma cells
Vinod Pullarkat et al.
LEUKEMIA RESEARCH (2014)
Nanotherapeutic approaches for brain cancer management
Laura Saenz del Burgo et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
A comparative study of the iron status of patients with oesophageal adenocarcinoma to determine suitability for a clinical trial of iron chelation therapy
S. J. Ford et al.
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND (2014)
Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo
S. J. Ford et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Deferasirox shows in vitro and in vivo antileukemic effects on murine leukemic cell lines regardless of iron status
Dae-Hyoung Lee et al.
EXPERIMENTAL HEMATOLOGY (2013)
Iron Chelation in the Treatment of Cancer: A New Role for Deferasirox?
Matthew R. Bedford et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Enhanced Brain Delivery of Deferasirox-Lactoferrin Conjugates for Iron Chelation Therapy in Neurodegenerative Disorders: In Vitro and in Vivo Studies
Golnaz Kamalinia et al.
MOLECULAR PHARMACEUTICS (2013)
Mechanism of the antitumoral activity of deferasirox, an iron chelation agent, on mantle cell lymphoma
Liat Vazana-Barad et al.
LEUKEMIA & LYMPHOMA (2013)
Iron metabolism in the CNS: implications for neurodegenerative diseases
Tracey A. Rouault
NATURE REVIEWS NEUROSCIENCE (2013)
Deferasirox and Vitamin D Improves Overall Survival in Elderly Patients with Acute Myeloid Leukemia after Demethylating Agents Failure
Etienne Paubelle et al.
PLOS ONE (2013)
The Iron Chelator, Deferasirox, as a Novel Strategy for Cancer Treatment: Oral Activity Against Human Lung Tumor Xenografts and Molecular Mechanism of Action
Goldie Y. L. Lui et al.
MOLECULAR PHARMACOLOGY (2013)
Challenges in drug delivery to tumors of the central nervous system: An overview of pharmacological and surgical considerations
Laura P. Serwer et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Gregg L. Semenza
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
The Oral Iron Chelator Deferasirox Induces Apoptosis in Myeloid Leukemia Cells by Targeting Caspase
Jung-Lim Kim et al.
ACTA HAEMATOLOGICA (2011)
Wnt Inhibitor Screen Reveals Iron Dependence of β-Catenin Signaling in Cancers
Siyuan Song et al.
CANCER RESEARCH (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Selective Acetylcholinesterase Inhibitor Activated by Acetylcholinesterase Releases an Active Chelator with Neurorescuing and Anti-Amyloid Activities
Hailin Zheng et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG
Francois Gaboriau et al.
BIOMETALS (2010)
Deferasirox is a powerful NF-κB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging
Emanuela Messa et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Radiation Resistance in Glioma Cells Determined by DNA Damage Repair Activity of Ape1/Ref-1
Mamta D. Naidu et al.
JOURNAL OF RADIATION RESEARCH (2010)
The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1
Junko H. Ohyashiki et al.
CANCER SCIENCE (2009)
Nanoparticle-chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: A novel therapeutic approach for Alzheimer disease
Gang Liu et al.
NEUROSCIENCE LETTERS (2009)
Regional hypoxia in glioblastoma multiforme quantified with [18F] fluoromisonidazole positron emission tomography before radiotherapy:: Correlation with time to progression and survival
Alexander M. Spence et al.
CLINICAL CANCER RESEARCH (2008)
Antiproliferative and apoptotic effects in rat and human hepatoma cell cultures of the orally active iron chelator ICL670 compared to CP20: a possible relationship with polyamine metabolism
G. Lescoat et al.
CELL PROLIFERATION (2007)
Involvement of Hif-1 in desferrioxamine-induced invasion of glioblastoma cells
Anja Elstner et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Deferasirox - A review of its use in the management of transfusional chronic iron overload
Lily P. H. Yang et al.
DRUGS (2007)
Nanoparticle iron chelators: A new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance
Gang Liu et al.
NEUROSCIENCE LETTERS (2006)
The new orally active iron chelator ICL670A exhibits a higher antiproliferative effect in human hepatocyte cultures than O-trensox
Karine Chantrel-Groussard et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Oral chelators deferasirox and defefiprone for transfusional iron overload in thalassen a major: new data, new questions
EJ Neufeld
BLOOD (2006)
'Pseudopalisading' necrosis in glioblastoma: A familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis
Yuan Rong et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
The evolution of iron chelators for the treatment of iron overload disease and cancer
DS Kalinowski et al.
PHARMACOLOGICAL REVIEWS (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate
HH Hoepken et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding
SM Evans et al.
CANCER RESEARCH (2004)
分享论文
